1. Introduction {#sec1}
===============

Patients who present to the pediatric emergency department (PED) have a high risk of medication errors, with rates of up to 5.7 medication errors per 100 orders \[[@bib1]\]. The most common type of medication error in the PED is overdose \[[@bib1]\]. The risk of these errors is high in the emergency department (ED), as there is a need to rapidly administer the medication after preparation using the ED\'s floor stock and under the stress of critical situations.

Urgent medical treatments are regularly prescribed in the PED and other hospital wards using the term "stat", which is derived comes from the Latin word "statim" for "immediately". This prescription term is intended to speed up orders that are required immediately, and stat medication orders should be administered within 30 min after the time they are ordered \[[@bib2]\]. However, numerous hospitals struggle to reliably administer stat medications in \<30 min, despite the fact that delayed medication administration can prolong the patient recovery time, prolong the hospital stay, and even harm the patient \[[@bib3]\]. Prompt administration of urgent medications is important for high-quality care, as delayed administration of anti-microbial agents is associated with increased mortality among sepsis patients and children with epilepticus \[[@bib4], [@bib5]\]. Nursing practice for drug ordering and delivery is typically divided into five stages: prescribing, transcribing, dispensing, administration, and monitoring, which must be observed carefully when nurses administer any type of drug \[[@bib1]\]. Errors can occur during the steps for prescribing the medication, reading the prescription, dispensing the medication, administering the medication, and controlling the drug(s) \[[@bib6]\].

The current practice at our tertiary care hospital focuses of nine "rights": the right patient, the right drug, the right route, the right dose and strength, the right time and in relation to meals, the right documentation, the right product label/integrity/purity/expiry date, the right to education/explanation, and the right to refuse treatment. All of these parameters must be documented and the communicated to the physician. Every medication order written by physicians is reviewed by an assigned nurse for appropriateness and clarification regarding the safe medication dose using our institution\'s drug formulary \[[Figure 1](#fig1){ref-type="fig"}\]. However, the calculations are performed manually by the nurses before the medication is administered to the patient, and this is tracked using a paperwork-based system for physician orders that is administered by nurses and other healthcare workers. This system is prone to calculation errors or delays in the administration of medication to the patient, which can be associated with different harms. Moreover, requesting, dispensing, and administering medications, as well as monitoring the treatment process, are becoming increasingly challenging processes for pediatric patients \[[@bib6], [@bib7]\]. Several strategies have been proposed to prevent and reduce medication errors, which target staff training, communicating information regarding new drugs, making pharmacology books available in the ward, medication-error analysis, computerized provider-order entry systems, automated dispensing cabinets, barcoded systems, medication reconciliation processes, and proper labelling of syringes according to the International Organization for Standardization guidelines \[[@bib1], [@bib6], [@bib8]\]. These measures can be used to prevent medication errors and thus increase the quality of care and patient safety \[[@bib6]\].Figure 1Barriers to timely medication administration.Figure 1

The present study aimed to develop and evaluate an automated intravenous dosage medication calculation tool (AIVDMCT) for reducing the interval from the time of order to the time of administration among children who were treated at a tertiary hospital\'s PED in Riyadh, Saudi Arabia.

2. Methods {#sec2}
==========

2.1. Study setting and design {#sec2.1}
-----------------------------

This prospective observational study was performed at the PED of a tertiary care hospital in Riyadh, Saudi Arabia. This institution includes four hospitals and four medical centers, which expect to treat \>19,171 inpatients annually and \>238,404 patients at the outpatient department and EDs. The PED had 26 beds to provide acute care and critical care to an average of 1,913 patients per month. The present study focused on the prescription of high-risk intravenous medications in the PED, which were defined as antibiotics, antiepileptic drugs, intravenous electrolyte replacement, frusemide, labetalol, mannitol, steroids, atropine, adenosine, insulin, morphine, fentanyl, milrinone, and inotropes.

This study evaluated an AIVDMCT that was designed to reduce the time from the order to administration of stat medications in the PED. The study flowchart and medication guidelines were reviewed, monitored, and renewed annually by a senior pharmacist and a registered nurse \[[Figure 1](#fig1){ref-type="fig"}\]. The tool considered patient demographic data, generic medication names, vial or ampule strength, physician dosage order, and dilution instructions with the rate of infusion for the nurses. Data were collected for pediatric patients (≤14 years old, body weight of ≤40 kg) who were prescribed high-risk medications in the PED during June--December 2016 (before the AIVDMCT was implemented) and during June--December 2017 (after the AIVDMCT was implemented). The study was approved by our institutional review board \[[Figure 2](#fig2){ref-type="fig"}\].Figure 2The automated intravenous dosage medication calculation tool.Figure 2

2.2. Study intervention {#sec2.2}
-----------------------

The AIVDMCT and a review guideline system were developed by a quality improvement (QI) core team, which included pediatric consultant physicians, registered pediatric nurses, senior pharmacists, and a Microsoft Excel expert engineer. The pediatric consultant physicians, senior pharmacists, and registered pediatric nurses were involved to ensure that the information was collected accurately and reflected important safety considerations. The pediatric consultant physicians and senior pharmacists defined the standard medication doses, and the pharmacists and nurses standardized the medication preparation and administration procedures.

The tool was developed based on an Excel spreadsheet for cardiopulmonary resuscitation, which includes the stat and infusion medications, as well as dosage calculations for weights of 1--40 kg \[[Figure 3](#fig3){ref-type="fig"}\]. At the end of 2017, the QI core team developed the AIVDMCT using a secured Excel spreadsheet to record the safe and proper medication administration processes, which included dosage calculations, preparation processes, and appropriate administration times for pediatric patients with body weights of 1--40 kg. The standard formulas were used from our tertiary hospital-approved medication guidelines, with oversight from the pharmacy team and conversion into the automated tool by the Microsoft Excel engineer.Figure 3A spreadsheet based on body weight that includes the STAT and infusion medication doses.Figure 3

The AIVDMCT system included the medical record number (MRN), patient name, patient age, patient weight, generic medication name, vial or ampule strength, physician dosage order, and dilution instructions with rate of infusion for the nurses \[[Figure 2](#fig2){ref-type="fig"}\]. The AIVDMCT system was installed on all computers in the PED, which allowed the nurses to enter the patient\'s MRN and weight in kg, as well as the name of the medication and the physician-ordered medication dosage. The system automatically generates a list of medication options with the calculated intravenous dosage based on the drug strength and patient weight. The nurses were encouraged to contact the pharmacist to ensure that all patients received the correct medication, especially if the patient had a condition that might alter the medication dose or administration (e.g., allergies, medical disorders, abnormal laboratory test results, or other conditions). When the medication was approved by the pharmacy, one nurse prepared the medication and a second nurse performed manual checks to confirm the medication calculations. The first nurse then confirmed the patient\'s identity based on their first, middle, and last names, as well as the MRN. When the patient\'s identify has been confirmed, the medication is administered using the proper technique \[[Figure 1](#fig1){ref-type="fig"}\]. A team of nurses and pharmacists was assembled to follow the medication processes from the order to the administration, which identified barriers to timely medication administration. The nursing staff were also educated regarding the AIVDMCT and how to properly use that system.

The following information was collected for each medication order: medication name, date ordered, time of order (TO) by the physician, and time of preparation (TP) and time of administration (TA) by the nurses. This information was collected into an Excel spreadsheet to evaluate these times before and after the implementation of the AIVDMCT. The TO was defined as the time at which the physician placed the medication order. The TP was defined as the time that the nurse entered the order into the AIVDMCT and retrieved the medication from the PED floor stock or the pharmacy. The TA was defined as the time at which the patient received the medication. All medication orders were prospectively reviewed by the QI core team before and after the AIVDMCT was implemented, and a physician was consulted for cases that required further clarification. The QI core team collected data from the patients\' electronic medical records on a monthly basis during June--December 2016 (before the AIVDMCT was implemented) and during June--December 2017 (after the AIVDMCT was implemented). Data were not collected for other months during the study period because of staffing issues at the time.

2.3. Procedures and evaluations {#sec2.3}
-------------------------------

This study involved several steps. First, the study was conceived after a brief literature review. Second, a study flowchart was created for the project proposal. Third, we performed a comprehensive literature review before creating the AIVDMCT system and collecting and analyzing the data. Patient anonymity was preserved at all steps, with the patients\' names and MRNs stored in a safe and secure location. Raw data were treated with strict confidentiality and only used for research purposes.

A self-administered questionnaire was developed by the QI core team to evaluate the AIVDMCT. Before the questionnaire was distributed, the questioner was pre-tested and validated. Pilot study was done among 40 nurses. Minor modifications were made, which were intended to minimize ambiguity and to enhance clarity and simplicity. The questionnaire required an average of 10--15 min to complete, and was randomly sent to pediatric registered nurses who worked in the PED and provided informed consent to participate in the survey.

Each nurse received the questionnaire along with a cover letter explaining the project. The questionnaire focused on 12 statements regarding the AIVDMCT, which were scored based on a 5-point Likert scale (strongly agree, agree, undecided, disagree, and strongly disagree). The questionnaire statements were: "the AIVDMCT is easy to use", "I feel confident that I am not harming the patient via medication errors", "the AIVDMCT covers the most commonly used medications in my department", "the AIVDMCT is based on the KFMC drug formulary and/or PALS guidelines", "the awareness session provided a positive learning environment", "the tool fulfilled the expectations from the previous cardiopulmonary resuscitation sheet", "I am overall satisfied with the AIVDMCT", and "I recommend the AIVDMCT to the Children Specialized Hospital or pediatric critical care areas".

The primary statistical test included a descriptive analysis of the survey questions. All continuous variables such as TO - TP, TP -- TA and TO -- TA expressed as Mean ± S.D. Paired sample t-test was applied to determine the mean significant differences pre and post observations of TO -- TP, TP -- TA and TO -- TA. P -- value less than 0.05 consider as statistically significant. All data entered and analyzed through Statistical Package for Social Sciences 25 (SPSS Inc., Chicago, IL, USA).

3. Results {#sec3}
==========

The present study evaluated data from 328 eligible cases, including 164 cases from the pre-implementation period (June--December 2016) and the 164 cases from the post-implementation period (June--December 2017) \[[Table 1](#tbl1){ref-type="table"} and [Figure 4](#fig4){ref-type="fig"}\]. During the pre-implementation period, the average interval from the TO to the TP was 31.52 ± 16.38 min and the average interval from the TP to the TA was 7.98 ± 6.39 min. The overall time from order to administration was 39.55 ± 19.34 min during the pre-implementation period \[[Table 2](#tbl2){ref-type="table"} and [Figure 4](#fig4){ref-type="fig"}\]. During the post-implementation period, significantly reduced intervals were observed for TO to TP (average time: 8.05 ± 3.42 min) and for TP to TA (average time: 3.74 ± 1.70 min). Moreover, there was a significant reduction in the interval from TO to TA (average time: 11.79 ± 4.48 min, P \< 0.001) \[[Table 2](#tbl2){ref-type="table"} and [Figure 5](#fig5){ref-type="fig"}\]. The nurses\' feedback regarding the ADIVMCT revealed 100% satisfaction that they were avoiding patient harm, saving time in critically ill or deteriorating cases, and that the tool was user-friendly and secure.Table 1Before and after implementation of the automated intravenous dosage medication calculation tool according to calendar.Table 1TO--TPAutomated intravenous dosage medication calculation toolP-valueBefore 2016 (n = 164)After 2017 (n = 164)June30.49 ± 17.227 ± 2.53\<0.001July29.38 ± 18.315.33 ± 1.05\<0.001August25.61 ± 12.379.91 ± 3.87\<0.001September35.5 ± 17.5411.55 ± 2.5\<0.001October38.33 ± 12.959.83 ± 2.55\<0.001November42.33 ± 21.127.73 ± 2.96\<0.001December26.82 ± 7.84.82 ± 0.73\<0.001**TP--TA**June8.7 ± 5.593.03 ± 1.52\<0.001July7.83 ± 5.022.96 ± 0.55\<0.001August7.33 ± 10.673.82 ± 2.110.080September7.25 ± 3.495.1 ± 2.290.016October7.78 ± 4.734.33 ± 1.240.013November10.33 ± 5.54.73 ± 0.96\<0.001December6.82 ± 2.833.12 ± 0.490.002**TO--TA**June39.19 ± 20.3710.03 ± 3.18\<0.001July37.21 ± 21.088.29 ± 1.43\<0.001August32.94 ± 18.8313.73 ± 5.31\<0.001September42.75 ± 18.4716.65 ± 4.03\<0.001October46.11 ± 15.4314.17 ± 2.9\<0.001November53.33 ± 21.4412.47 ± 3.14\<0.001December33.65 ± 9.777.94 ± 0.9\<0.001[^1][^2]Figure 4Before and after implementation of the automated intravenous dosage medication calculation tool according to month. A) Time of order (TO) to time of preparation (TP). B) Time of preparation (TP) to time of administration (TA). C) Time of order (TO) to time of administration (TA).Figure 4Table 2Overall analysis of times from before and after the AIVDMCT implementation.Table 2VariablesBefore 2016 (n = 164)After 2017 (n = 164)P-valueTO--TP31.52 ± 16.388.05 ± 3.42\<0.001TP--TA7.98 ± 6.393.74 ± 1.70\<0.001TO--TA39.55 ± 19.3411.79 ± 4.48\<0.001[^3][^4]Figure 5Analysis of timings before and after implementation of the automated intravenous dosage medication calculation tool. Data are shown in minutes. TO: time of order, TP: time of preparation, TA: time of administration.Figure 5

4. Discussion {#sec4}
=============

The present study revealed that implementation of the AIVDMCT was associated with a significant reduction in the average time from TO to TA (from 39.55 ± 19.34 min to 11.79 ± 4.48 min), with an increased proportion of stat medications that were administered within the target window.

Although the overuse of stat orders is well-documented, few studies have evaluated the turnaround times that hospitals can achieve for administering stat medication orders \[[@bib3], [@bib9]\]. The present study revealed that an AIVDMCT system was associated with a significant reduction in the time from medication order to administration, with average times of \<30 min. A similar study at the neonatal intensive care unit of the Cincinnati Children\'s Hospital Medical Center revealed a potential reduction in the medication administration time from 256 min to 35 min after implementing an automated medication administration system \[[@bib10]\]. In addition, a study at Aramco Johns Hopkins in Saudi Arabia revealed a decrease in the time needed to deliver stat medications (from 59.7 min to 40.7 min) after the implementation of multiple systems, which included structured communication, an electronic inbox for stat medication orders sent by nurses to the pharmacy, and the use of a pink envelope for delivering stat medication orders \[[@bib2]\]. Another study at the Kimball Medical Center in New Jersey revealed that the median time needed to process non-physician-entered orders was significantly less than that needed for physician-entered orders (27 min vs. 34 min) \[[@bib11]\]. However, another study from the United States revealed that "ward bay wall charts" for documenting and communicating stat medications actually increased the median time to administration (from 94 min to 146 min, a 55% increase), which was associated with delayed medication delivery and poorer communication \[[@bib3]\]. Despite the limited number of studies, those findings may help guide the determination of medication error severity, and may be useful for educating physicians regarding innovative methods that can be used to confirm the correct and safe dosages for their patients.

5. Conclusion {#sec5}
=============

The present study revealed that the AIVDMCT was associated with a significant reduction in the interval from the TO to the TA, which increased the proportion of stat medications that were administered in the target window. In our center, the AIVDMCT is complemented by other systems that can help reduce the time to medication administration, such as computerized provider-order entry systems, automated dispensing cabinets, barcoding systems, and medication reconciliation. Hospitals that have undesirably long times to medication administration should consider whether implementing these strategies can help reduce their medication administration times.

5.1. Recommendations {#sec5.1}
--------------------

We recommend that hospitals and emergency staff members identify and address any modifiable variables that could lead to delays in the administration of these often life-saving medications. It is also critical that institutions create and promote awareness regarding ways to reduce medication errors through multiple strategies, which can include medication-error analysis, automated dispensing cabinets, barcoding systems, medication reconciliation, standardizing medication-use processes, and education for emergency department nurses, physicians, and clinical pharmacists. It may also be prudent to incorporate patient outcomes into related research, which would allow studies to determine whether outcomes are improved by reducing the time from order to administration of stat medications.

5.2. Limitations {#sec5.2}
----------------

The present study has several limitations. First, we did not have access to data regarding patient outcomes, which would be needed to determine whether reducing the time to administration of stat medications was associated with improved outcomes. Second, we did not collect data regarding orders that were designated as stat but were later excluded. Third, staffing limitations resulted in some data not being collected during several months in the study period. Fourth, we were not able to control for all variables that might have influenced the turnaround time for stat medications during the study period. Therefore, the present study cannot definitively demonstrate that there was a causal relationship between implementing the AIVDMCT system and reducing the time to stat medication administration.
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[^1]: Results are shown in minutes (mean ± standard deviation).

[^2]: TO: time of order, TP: time of preparation, TA: time of administration.

[^3]: Results are shown in minutes (mean ± standard deviation).

[^4]: TO: time of order, TP: time of preparation, TA: time of administration.
